Abstract
Targeted drug delivery using nanocrystalline materials delivers the drug at the deseased site. This increases the efficacy of the drug in killing the cancer cells. Surface modifications were done to target the drug to a particular receptor on the cell surface. This paper reports synthesis of hydroxyapatite and titanium dioxide nanoparticles and modification of their surface with polyethylene glycol (PEG) followed by folic acid (FA). Paclitaxel, an anticancer drug, is attached to functionalized hydroxyapatite and titanium dioxide nanoparticles. The pure and functionalised nanoparticles are characterised with XRD, TEM and UV spectroscopy. Anticancer analysis was carried out in DEN induced hepatocarcinoma animals. Biochemical, hematological and histopathological analysis show that the surface modified paclitaxel attached nanoparticles have an higher anticancer activity than the pure paclitaxel and surface modified nanoparticles without paclitaxel. This is due to the targeting of the drug to the folate receptor in the cancer cells.
Similar content being viewed by others
References
G.I. Abeleb, Cancer Res. 28, 1344 (1986)
A.C. Antony, Annu. Rev. Nutr. 16, 501 (1996)
D. Bailey, K. Mujoo, M.E. Blake, C.J. Arntxen, J.U. Gutter-man, PNAS USA 98, 5821 (2001)
D.D. Banker, Indian J. Med. Sci. 57, 511 (2003)
R. Benoit, D. Breuille, F. Rambourdin, G. Bayle, P. Capitan, C. Obled, Am. J. Physiol. Endocrinol. Metab. 279, 244 (2000)
R. Castino, M. Demoz, C. Isidoro, J. Mol. Recognit. 16, 337 (2003)
C.K. Chang, G. Astrakianakis, D.B. Thomas, N.S. Seixas, R.M. Ray, D.L. Gao, K.J. Wernli, E.D. Fitzgibbons, T.L. Vaughan, H. Checkoway, Int. J. Epidemiol. 35, 361 (2006)
M. Cheesbrough, District laboratory practice in tropical countries. Part 1 (Cambridge University Press, Cambridge, 1998), p. 348
D. Chowdhury, A. Paul, A. Chattopadhyay, Langmuir 21, 4123 (2005)
C.R. Dass, T. Su, Drug Deliv. 8, 191 (2001)
N. Desai, J. Hubbell, Macromolecules 25, 226 (1992)
G. Devanand Venkatasubbu, S. Ramasamy, G.S. Avadhani, L. Palanikumar, J. Kumar, J. Nanoparticle Res. (2012). doi:10.1007/s11051-012-0819-3
G. Devanand Venkatasubbu, S. Ramasamy, G.S. Avadhani, V. Ramakrishnan, J. Kumar, Powder Technol. 235, 437 (2013)
C.H. Dubin, Mech. Eng. Nanotechnol. 126, 10 (2004)
S. Fiala, E.S. Fiala, J. Natl. Cancer Inst. 51, 151 (1973)
B.A. Gruner, S.D. Weitman, Investig. New Drugs 16, 205 (1998)
R.L. Gutman, G. Peacock, D.R. Lu, J. Control. Release 65, 31 (2000)
W.S. Ha, C.K. Kim, S.H. Sung, C.B. Kang, J. Vet. Sci. 2, 53 (2001)
J.A. Halsted, C.H. Halsted, The laboratory in clinical medicine: interpretation and application, 2nd edn. (WB, Saunders Company, Philadelphia, 1991), p. 281
M. Hamadanian, A.R. Vanani, A. Majedi, J. Iran. Chem. Soc. 7, S52 (2010)
M. Hanigan, H. Pitot, Carcinogenesis 6, 165 (1985)
Y. Hu, J. Xie, Y.W. Tong, C.H. Wang, J. Control. Release 118, 7 (2007)
L. Illum, S.S. Davis, R.H. Miiller, E. Mak, P. West, Life Sci. 40, 367 (1987)
J. Iqbal, M. Minhajuddin, Z.H. Beg, Eur. J. Cancer Prev. 13, 515 (2004)
A. Jemal, T. Murray, E. Ward, A. Samuels, R.C. Tiwari, A. Ghafoo, E.J. Feuer, M.J. Thun, Cancer J. Clin 55, 10 (2005)
J. Jiang, P.N. Ehle, N. Xu, Lipids Health Dis 5, 4 (2006)
T.H. Kang, H.O. Pae, J.C. Yoo, N.Y. Kim, Y.C. Kim, G.I. Ko, H.T. Chung, J. Ethnopharmacol. 70, 177 (2000)
T. Kobayashi, T. Kawakubo, Cancer 73, 1946 (1994)
B. Koss, O. Greengurd, Cancer Res. 42, 2146 (1982)
M. Kurt, I.K. Sayilir, Y. Beyazit, E.O.M. Kekilli, N.T.K. Karaman, M. Akdogan, Hepato-Gastroenterology 59, 1580 (2012)
H.L. Lin, T.Y. Liu, G.Y. Chau, W.Y. Lui, C.W. Chi, Cancer 89, 983 (2000)
S.C.J. Loo, Y.E. Siew, S. Ho, F.Y.C. Boey, J. Mater. Sci. Mater. Med. 19, 1389 (2008)
N.M.P. Maideen, R. Velayutham, G. Manavalan, Asian J. Pharm. Life Sci. 2, 1 (2012)
S. Malomo, Nig. J. Biochem. Mol. Biol. 15, 33 (2000)
A. Manivannan, G. Glaspell, P. Dutta, J. Clust. Sci. 19, 391 (2008)
S. Mucisc, M. Goti, M. Ivanda, S. Popovi, A. Turkovi, R. Trojko, A. Sekuli, K. Furi, Mater. Sci. Eng. B47, 33 (1997)
H.T. Ong, J.S.C. Loo, F.Y.C. Boey, S.J. Russell, J. Ma, K. Peng, J. Nanoparticle Res. 10, 141 (2008)
J. Pan, S.-S. Feng, Biomaterials 29, 2663 (2008)
A.Y. Pataquiva Mateus, M.P. Ferraz, F.J. Monteiro, Key Eng. Mater. 330, 243 (2007)
P.S. Patel, G.N. Rawal, D.B. Bala, Tumor Biol. 15, 45 (1994)
T. Rajh, L.X. Chen, K. Lukas, T. Liu, M.C. Thurnauer, D.M. Tiede, J. Phys. Chem. B 106, 10543 (2002)
D. Robert, J.V. Weber, J. Mater. Sci. Lett. 18, 97 (1999)
E. Rocchi, Y. Seium, L. Camellini, G. Casalgrandi, A. Borghi, P. D’Alimonte, G. Cioni, Hepatology 26, 67 (1997)
T.M. Saba, Arch. Intern. Med. 126(1031) (1970)
R. Sallie, J.M. Tredger, R. Willam, Drug Dispos 12, 251 (1991)
G. Schumann, R. Bonora, F. Ceriotti, Clin. Chem. Lab. Med. 40, 718 (2002)
A. Sehrawat, S. Sultana, Life Sci. 79, 1456 (2006)
F. Siepmann, S. Muschert, M.P. Flament, P. Leterme, A. Gayot, Int. J. Pharm. 317, 136 (2006)
P.J. Stevens, M. Sekido, R.J. Lee, Pharm. Res. 21, 2153 (2004)
B.A.J. Sudimack, R.J. Lee, Adv. Drug Deliv. Rev. 41, 147 (2000)
C. Thirunavukkarasu, D. Sakthisekaran, Cell Biochem. Funct. 21, 147 (2003)
C.D. Thomson, Analyst 123, 827 (1998)
N. Thusu, P.N. Raina, R.K. Johri, Indian J. Exp. Biol. 29, 1124 (1991)
V.P. Torchilin, Eur. J. Pharm. Sci. 11(S81) (2000)
A.J. Vanisree, C.S. Shyamala Devi, Indian J. Pharmacol. 31(275) (1998)
S.P. Vyas, V. Sihorkar, Adv. Drug Deliv. Rev. 43(101) (2000)
S. Watson, D. Beydoun, J. Scott, R. Amal, J. Nanoparticle Res. 6, 193 (2004)
S.D. Weitman, R.H. Lark, L.R. Coney, D.W. Fort, V. Frasca, V.R. Zurawski Jr., B.A. Kamen, Cancer Res. 52, 3396 (1992)
Z. Xu, W. Gu, J. Huang, H. Sui, Z. Zhou, Y. Yang, Z. Yan, Y. Li, Int. J. Pharm. 288, 361 (2005)
J. Yamamoto, T. Kosuge, T. Takayama, K. Shimada, S. Yamasaki, H. Ozaki, N. Yamaguchi, M. Makuuchi, Br. J. Surg. 83, 1219 (1996)
M. Yokoyama, J. Artif. Organs 8, 77 (2005)
J. Zang, S. Rana, R.S. Srivastava, R.D.K. Misra, Acta Biomater. 4, 40 (2008)
Acknowledgments
Prof. S. Ramasamy, CSIR Emeritus Scientist, acknowledge the financial support given to him to carry out this work under CSIR Emeritus Scientist Scheme number 21(0714)/08/EMR-II dated 28-04-2008. Mr. G. Devanand Venkatasubbu, CSIR SRF, acknowledge CSIR for giving him SRF. The authors are greatful to Dr. (Mrs).V. Meenakumari M.A, M.Phil, Ph.D, Professor, Department of English, A.P.A college for Women, Palani, India (An autonomous college of Mother Theresa University) for making English correction in the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Venkatasubbu, G.D., Ramasamy, S., Reddy, G.P. et al. In vitro and In vivo anticancer activity of surface modified paclitaxel attached hydroxyapatite and titanium dioxide nanoparticles. Biomed Microdevices 15, 711–726 (2013). https://doi.org/10.1007/s10544-013-9767-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10544-013-9767-7